Avenue Therapeutics Inc. (ATXI)
undefined
undefined%
At close: undefined

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -10.38M -3.60M -3.73M -5.15M -25.91M -21.55M -12.26M -3.18M -5.23M
Depreciation & Amortization - - - - - - 174.00K - -
Stock-Based Compensation 906.00K 649.00K 442.00K 710.00K 1.84M 1.54M 604.00K 28.00K 55.64
Other Working Capital 70.00K 23.00K -55.00K 57.00K 982.00K 670.00K -154.00K 1.07M 1.17M
Other Non-Cash Items 310.00K -5.05M 909.00K 939.00K 61.00K 412.00K 2.32M 435.00K 3.16M
Deferred Income Tax - - - - - - 277.00K - -
Change in Working Capital -290.00K 408.00K -461.00K -172.00K -2.25M 1.79M 2.08M 1.08M 1.17M
Operating Cash Flow -9.45M -7.60M -3.75M -4.61M -26.26M -18.22M -6.80M -1.63M -895.00K
Capital Expenditures -3.00M - - -1.00M - - - - -3.00M
Acquisitions - - - - - - - - -
Purchase of Investments - - - - -5.00M 10.00M -10.00M - -
Sales Maturities Of Investments - - - - 5.00M 10.00M - - -
Other Investing Acitivies -3.00M - - -1.00M - -10.00M -10.00K - -3.27K
Investing Cash Flow -3.00M - - -1.00M - 10.00M -10.00M - -3.00M
Debt Repayment - - - - - - -3.00M 1.87M 3.91M
Common Stock Repurchased - -1.10M - - - - - - -
Dividend Paid - - - - - - - - -
Other Financial Acitivies 1K 148.00K -663.00K - -2.67M -895.00K -6.56M -58.00K -
Financial Cash Flow 7.53M 10.54M 4.38M - 32.33M -895.00K 28.39M 1.81M 3.91M
Net Cash Flow -4.92M 2.94M 631.00K -5.61M 6.07M -9.11M 11.59M 183.00K 14.00K
Free Cash Flow -12.45M -7.60M -3.75M -5.61M -26.26M -18.22M -6.80M -1.63M -3.90M